tradingkey.logo
搜索

Clearmind Medicine Inc

CMND
添加自选
1.685USD
+0.065+4.01%
收盘 07-31 16:00美东报价延迟15分钟
171.72K总市值
亏损市盈率 TTM

关于 Clearmind Medicine Inc 公司

Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Clearmind Medicine Inc简介

公司代码CMND
公司名称Clearmind Medicine Inc
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)
员工数量- -
证券类型Ordinary Share
年结日Aug 10
公司地址101-1220 West 6Th Avenue
城市VANCOUVER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编V6H 1A5
电话16042601566
网址https://www.clearmindmedicine.com/
公司代码CMND
上市日期Aug 10, 2021
CEOZuloff-Shani (Adi)

Clearmind Medicine Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%
Mr. Yehonatan Shachar
Mr. Yehonatan Shachar
Independent Director
Independent Director
--
--
Ms. Hila Kiron-Revach
Ms. Hila Kiron-Revach
Director
Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Amitay Weiss
Mr. Amitay Weiss
Independent Chairman of the Board
Independent Chairman of the Board
462.00
+78.35%
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Independent Director
Independent Director
187.00
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
94.00
--
Mr. Alan Rootenberg
Mr. Alan Rootenberg
Chief Financial Officer
Chief Financial Officer
71.00
+11.27%
Dr. Adi Zuloff-Shani
Dr. Adi Zuloff-Shani
Chief Executive Officer
Chief Executive Officer
--
--
Prof. Mark Haden
Prof. Mark Haden
Vice President - Business Development
Vice President - Business Development
--
-100.00%

常见问题

Clearmind Medicine Inc的前五大股东是谁?

Clearmind Medicine Inc 的前五大股东如下:Mr. Amitay Weiss

有多少机构持有Clearmind Medicine Inc(CMND)的股份?

截至2026Q1,共有18家机构持有Clearmind Medicine Inc的股份,合计持有的股份价值约为7.38K,占公司总股份的0.49%。与2025Q4相比,机构持股有所增加,增幅为-15258.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有